Dr. Reddy’s Expands U.S. Presence with Purchase of BASF’s Contract Manufacturing Franchise
Dr. Reddy’s Laboratories plans to acquire BASF’s pharmaceutical contract manufacturing business and related facility in Shreveport, LA. The transaction is expected to close by the first quarter of fiscal year 2009.
This segment of BASF involves the manufacturing of generic prescription and over-the-counter products for branded and generic companies in the U.S. It reportedly recorded revenues of $43 million for 2007.
Comments